Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2025-12-25 @ 2:23 AM
NCT ID: NCT02565134
Eligibility Criteria: Inclusion Criteria: * Male and female patients aged 19 - 70 years * Patients who have eczema or xerosis cutis at the area where investigational product is applied (arm or leg) * Patients whose result of the pruritus test (Visual Analogue Scale, VAS) at Visit 1 and 2 is 5 or more * Patients whose overall dry skin score of the area where investigational product is applied at Visit 1 and 2 is 2 points or more Exclusion Criteria: * Patients with pruritus caused by other medical, psychotic and nervous causes other than the skin disease * Patients with such skin diseases as malignant tumor or chronic urticaria among patients with skin diseases * Patients with simple pruritus caused by such allergic material as scabies, and insect bite wound * Patients with the symptom of systemic infection at the time of the participation in the clinical study * Patients with a history of taking topical treatment drug, topical steroid agent or antibiotics for the treatment of pruritus within 2 weeks * Patients with a history of taking oral steroid agent within 4 weeks * Patients with a history of taking a physical treatment for the treatment of pruritus including phototherapy within 4 weeks * Pregnant or breast-feeding women * Women at a childbearing age who has childbearing potential or has a plan to get pregnant during the clinical study period
Healthy Volunteers: False
Sex: ALL
Minimum Age: 19 Years
Maximum Age: 70 Years
Study: NCT02565134
Study Brief:
Protocol Section: NCT02565134